P&S Market Research - A market research firm

Anaphylaxis Therapeutics Pipeline Analysis

Anaphylaxis Therapeutics Pipeline Analysis 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

Delivery : 1-2 Working Days
Report Code: LS11164
Available Format:

Anaphylaxis is a severe and rapid systemic allergic reaction to a trigger substance, known an allergen. Minute amounts of trigger substances may cause a life-threatening anaphylactic reaction. Anaphylaxis may occur after ingestion, inhalation, skin contact or injection of a trigger substance. The most severe type of anaphylaxis is known as anaphylactic shock that is usually fatal, if untreated. Anaphylaxis requires immediate medical treatment, including an immediate injection of epinephrine and a trip to a hospital emergency room. Accurate diagnosis and successful management of allergies is important. Some of the drug candidates in the anaphylaxis pipeline include, but are not limited to, Epinephrine sublingual soluble film and inhalable epinephrine. Some of the companies having drugs for anaphylaxis in pipeline are, MannKind Corp., and Monosol Rx LLC.

The report provides a comprehensive understanding of the pipeline activities covering all drug candidates under various stages of development, with detailed analysis of pipeline and clinical trials. Pipeline analysis of drugs by phases includes product description and development activities including information about clinical results, designations, collaborations, licencing, grants, technology and others.

Place An Order

Single User License

The report will be delivered in PDF format without printing rights. It is recommended for a single user.

USD 3250
Group License

The report will be delivered in PDF format along with the printing rights. It is recommended for up to five users.

USD 4000
Enterprise License

The report will be delivered in PDF format along with printing rights and detailed Excel sheet. It is recommended for organizations where multiple people would like to access the report from multiple locations.

USD 7750

Pre-Purchase Enquiry